Oon & Bazul’s Corporate Practice advised Fishawack Health, a leading life science commercialisation partner, in its acquisition of PRMA Consulting

Oon & Bazul’s Corporate Practice, led by Head of Mergers & Acquisitions, Ng Yi Wayn, successfully advised and acted for Fishawack Health, a leading life science commercialization partner, in its acquisition of PRMA Consulting, a premier global market access and health economics outcomes research consultancy with offices across Europe, Asia and the US, by way of a statutory merger, for an undisclosed amount.

Fishawack Health UK Bidco Limited, a leading life science commercialization partner, acquired PRMA Consulting (“PRMA”), a premier global market access and health economics outcomes research (HEOR) consultancy with offices across Europe, Asia and the US, by way of a statutory merger.

The acquisition bolsters Fishawack’s strong strategic offering, adding deep expertise in Asia-Pacific and European markets to complement the company’s existing market access offering in North America, resulting in Fishawack now offering one of the industry’s leading market access and HEOR capabilities, spanning the globe.

We worked alongside Fishawack’s counsels in the United Kingdom, to provide Fishawack with legal assistance on matters relating to the Singapore law and the Singapore entity, including the conducting of due diligence on PRMA, advice on the definitive agreements and closing matters.